Dr Michael D Obrien, MD | |
1378 Nw 124th St, Suite 200, Clive, IA 50325-8151 | |
(515) 288-6097 | |
(515) 288-6099 |
Full Name | Dr Michael D Obrien |
---|---|
Gender | Male |
Speciality | Gastroenterology |
Experience | 32 Years |
Location | 1378 Nw 124th St, Clive, Iowa |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1295793420 | NPI | - | NPPES |
0122135 | Medicaid | IA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RG0100X | Internal Medicine - Gastroenterology | 30471 (Iowa) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Unitypoint Health - Des Moines Iowa Methodist Medi | Des moines, IA | Hospital |
Mercyone Des Moines Medical Center | Des moines, IA | Hospital |
Greene County Medical Center | Jefferson, IA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Iowa Digestive Disease Center Pc | 4183522188 | 22 |
News Archive
Ambulance diversions from nearby, crowded New York emergency rooms to more distant emergency departments are associated with increased deaths among patients suffering from heart attacks, according to a paper presented at a meeting of the Institute for Operations Research and the Management Sciences (INFORMS®).
It has been known for about a year that minks can become infected with SARS-CoV-2. The virus had been transmitted from humans to farmed mink and mutated in infected animals.
Perrigo Company plc today announced that it has received final approval from the U.S. Food & Drug Administration for its abbreviated new drug application for repaglinide tablets 1 mg and 2 mg, the generic equivalent to Prandin Tablets (repaglinide tablets) and has commenced shipment of product. Perrigo previously launched the 0.5 mg strength in 2013.
CrystalGenomics, Inc., a novel drug R&D company announced today that the Phase I SAD (Single Ascending Dose) study for its novel antibiotic candidate, CG400549, has been successfully completed in Europe.
A new study has found that "skinny fat" - the combination of low muscle mass and strength in the context of high fat mass - may be an important predictor of cognitive performance in older adults.
› Verified 7 days ago
Entity Name | Iowa Digestive Disease Center Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1275571747 PECOS PAC ID: 4183522188 Enrollment ID: O20031229000890 |
News Archive
Ambulance diversions from nearby, crowded New York emergency rooms to more distant emergency departments are associated with increased deaths among patients suffering from heart attacks, according to a paper presented at a meeting of the Institute for Operations Research and the Management Sciences (INFORMS®).
It has been known for about a year that minks can become infected with SARS-CoV-2. The virus had been transmitted from humans to farmed mink and mutated in infected animals.
Perrigo Company plc today announced that it has received final approval from the U.S. Food & Drug Administration for its abbreviated new drug application for repaglinide tablets 1 mg and 2 mg, the generic equivalent to Prandin Tablets (repaglinide tablets) and has commenced shipment of product. Perrigo previously launched the 0.5 mg strength in 2013.
CrystalGenomics, Inc., a novel drug R&D company announced today that the Phase I SAD (Single Ascending Dose) study for its novel antibiotic candidate, CG400549, has been successfully completed in Europe.
A new study has found that "skinny fat" - the combination of low muscle mass and strength in the context of high fat mass - may be an important predictor of cognitive performance in older adults.
› Verified 7 days ago
Entity Name | Greene County Medical Center |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1245260652 PECOS PAC ID: 0143208595 Enrollment ID: O20040712000717 |
News Archive
Ambulance diversions from nearby, crowded New York emergency rooms to more distant emergency departments are associated with increased deaths among patients suffering from heart attacks, according to a paper presented at a meeting of the Institute for Operations Research and the Management Sciences (INFORMS®).
It has been known for about a year that minks can become infected with SARS-CoV-2. The virus had been transmitted from humans to farmed mink and mutated in infected animals.
Perrigo Company plc today announced that it has received final approval from the U.S. Food & Drug Administration for its abbreviated new drug application for repaglinide tablets 1 mg and 2 mg, the generic equivalent to Prandin Tablets (repaglinide tablets) and has commenced shipment of product. Perrigo previously launched the 0.5 mg strength in 2013.
CrystalGenomics, Inc., a novel drug R&D company announced today that the Phase I SAD (Single Ascending Dose) study for its novel antibiotic candidate, CG400549, has been successfully completed in Europe.
A new study has found that "skinny fat" - the combination of low muscle mass and strength in the context of high fat mass - may be an important predictor of cognitive performance in older adults.
› Verified 7 days ago
Entity Name | Iowa Endoscopy Center Inc |
---|---|
Entity Type | Part B Supplier - Ambulatory Surgical Center |
Entity Identifiers | NPI Number: 1609968478 PECOS PAC ID: 3870537897 Enrollment ID: O20050610000499 |
News Archive
Ambulance diversions from nearby, crowded New York emergency rooms to more distant emergency departments are associated with increased deaths among patients suffering from heart attacks, according to a paper presented at a meeting of the Institute for Operations Research and the Management Sciences (INFORMS®).
It has been known for about a year that minks can become infected with SARS-CoV-2. The virus had been transmitted from humans to farmed mink and mutated in infected animals.
Perrigo Company plc today announced that it has received final approval from the U.S. Food & Drug Administration for its abbreviated new drug application for repaglinide tablets 1 mg and 2 mg, the generic equivalent to Prandin Tablets (repaglinide tablets) and has commenced shipment of product. Perrigo previously launched the 0.5 mg strength in 2013.
CrystalGenomics, Inc., a novel drug R&D company announced today that the Phase I SAD (Single Ascending Dose) study for its novel antibiotic candidate, CG400549, has been successfully completed in Europe.
A new study has found that "skinny fat" - the combination of low muscle mass and strength in the context of high fat mass - may be an important predictor of cognitive performance in older adults.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Michael D Obrien, MD 1378 Nw 124th St, Suite 200, Clive, IA 50325-8151 Ph: (515) 288-6097 | Dr Michael D Obrien, MD 1378 Nw 124th St, Suite 200, Clive, IA 50325-8151 Ph: (515) 288-6097 |
News Archive
Ambulance diversions from nearby, crowded New York emergency rooms to more distant emergency departments are associated with increased deaths among patients suffering from heart attacks, according to a paper presented at a meeting of the Institute for Operations Research and the Management Sciences (INFORMS®).
It has been known for about a year that minks can become infected with SARS-CoV-2. The virus had been transmitted from humans to farmed mink and mutated in infected animals.
Perrigo Company plc today announced that it has received final approval from the U.S. Food & Drug Administration for its abbreviated new drug application for repaglinide tablets 1 mg and 2 mg, the generic equivalent to Prandin Tablets (repaglinide tablets) and has commenced shipment of product. Perrigo previously launched the 0.5 mg strength in 2013.
CrystalGenomics, Inc., a novel drug R&D company announced today that the Phase I SAD (Single Ascending Dose) study for its novel antibiotic candidate, CG400549, has been successfully completed in Europe.
A new study has found that "skinny fat" - the combination of low muscle mass and strength in the context of high fat mass - may be an important predictor of cognitive performance in older adults.
› Verified 7 days ago
Dr. Amol Agarwal, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1378 Nw 124th St, Clive, IA 50325 Phone: 515-288-6097 Fax: 515-288-8335 | |
Patricia Overton-keary, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1601 Nw 114th St, Clive, IA 50325 Phone: 515-222-7000 Fax: 515-222-7037 | |
Bernard Michael Feldman, D.O. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1601 Nw 114th St, Ste 342, Clive, IA 50325 Phone: 515-222-7600 Fax: 515-222-7643 | |
Melisa Coaker, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1275 Nw 128th St, Ste 200, Clive, IA 50325 Phone: 734-502-6716 Fax: 515-358-9650 | |
Kerry J Canady, DO Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1275 Nw 128th St, Ste 200, Clive, IA 50325 Phone: 734-502-6716 Fax: 515-225-6750 | |
Tercio Lopes, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1378 Nw 124th St, Clive, IA 50325 Phone: 515-288-6097 |